.png)
Brilliant Board Review & CME
🎙️ Brilliant Medicine: Your Internal Medicine Edge
Stay sharp, stay current, and stay confident with Brilliant Medicine — the go-to podcast for Internal Medicine and Family Medicine physicians, residents, nurse practitioners, and physician assistants.
Each episode delivers high-yield insights on the latest breakthroughs, practice-changing guidelines, and cutting-edge treatments in Internal Medicine — with just enough board review to keep your clinical reasoning razor-sharp.
We cut through the noise, simplify complex studies, and translate new data into actionable knowledge for your daily practice. Whether you're prepping for boards or staying ahead in clinic, hospital, or telemed — we've got your back.
🩺 Fast. Practical. Evidence-based.
This is the update your medical brain craves.
Brilliant Board Review & CME
🎙️ Episode 30: PAD Progress: Low-Dose Rivaroxaban Gets the Green Light
🧪 VOYAGER-PAD Trial:
Patients with PAD post lower extremity revascularization.
Rivaroxaban 2.5 mg BID + aspirin vs aspirin alone.
📈 Results:
↓ Major Adverse CV Events (MACE).
↓ Major Adverse Limb Events (MALE).
Modest ↑ in bleeding — no ↑ in fatal bleeds.
🧩 Clinical Takeaway:
Now guideline-endorsed for symptomatic PAD post-intervention.
Risk-benefit conversation needed in high-bleed-risk patients.